Conferences
16–18 October 2025, Estoril, Portugal
ESH 7th International Conference: Acute Myeloid Leukemia “Molecular and Translational”: Advances in Biology and Treatment—#ESHAML2025
Chairs: Bob Löwenberg, Hartmut Döhner, Benjamin Ebert
Venue: Estoril Congress Center
Av. Amaral,
2765-192 Estoril, Portugal
Start date: October 16, 2025
End date: October 18, 2025
About the conference:
The successful biannual ESH Conferences on acute myeloid leukemia (AML) have established themselves as scientific and educational programs at the interface of molecular and biological developments and clinical translation. Novel technological, molecular, and immunologic approaches are rapidly creating novel insights into the biology and therapeutic perspectives of AML.
The cutting-edge program of the conference will deal with the molecular and functional features of leukemic stem cells and their interaction with the microenvironment, the role of somatic and germ-line mutations and epigenetic alterations in the biology of AML, the genomics of leukemogenesis, advances in molecular diagnostics and developmental therapeutics with a focus on molecular and immunotherapeutic targeted therapeutics. Special attention will be given to the utility and promise of novel therapeutic agents.
Words from the Conference Chairs:
“We wish to invite and encourage you to join us at the ESH AML meeting upcoming in 2025. These conferences have an outstanding record of talks from international leaders in the basic science and clinical treatment of leukemia, along with robust discussions and many opportunities for interactions.
The seventh bi-annual conference in this series will offer discussions on the latest developments and emerging insights in the fascinating biology and rapidly changing clinical landscape of AML. For the attendees, it holds the promise of another inspiring interactive experience.”
–Hartmut Döhner, Benjamin Ebert and Bob Löwenberg
Continuing Medical Education (CME) credit points will be awarded to physicians for the time they spend at the meeting improving their knowledge and skills. ESH is a provider of the European Hematology CME system.
Conference Main Scientific Topics:
- Predisposition and Aging;
- Clonal Hematopoiesis;
- Targeting Clonal Hematopoiesis;
- Therapeutic Targeting 1;
- Metabolic and Proteomic Alterations;
- Cellular Therapy;
- Therapeutic Targeting 2;
- Measurable Residual Disease in AML;
- Therapeutic Targeting 3;
- Therapeutic Targeting 4.
This meeting will be valuable to those seeking the following:
- A cutting-edge scientific program—from basic science to clinical and therapeutic applications and perspectives;
- Multiple opportunities for scientific interaction with an international faculty of distinguished experts;
- An emphasis on critical discussion.
The meeting will provide clinicians and scientists with state-of-the-art recommendations regarding patient care and with insight into controversies in the field.
The meeting will be of interest to:
- PhD students, postdocs, junior and senior biologists, and practicing clinicians (MD, PhD, MD-PhD), hematologists, and oncologists in training;
- Residents and biologists in training.
The program will include the following:
- Plenary Sessions;
- Panel Discussions;
- Simultaneous Meet the Expert Sessions;
- Mentored Poster Walks;
- Ample time for in-depth discussion.
